GSK4527363
/ GSK
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 12, 2025
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants
(clinicaltrials.gov)
- P1 | N=142 | Recruiting | Sponsor: GlaxoSmithKline | Trial completion date: Jun 2027 ➔ Jan 2028 | Trial primary completion date: Jun 2027 ➔ Jan 2028
Trial completion date • Trial primary completion date • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
December 13, 2024
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants
(clinicaltrials.gov)
- P1 | N=112 | Recruiting | Sponsor: GlaxoSmithKline | Not yet recruiting ➔ Recruiting
Enrollment open • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
1 to 2
Of
2
Go to page
1